注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
主要投资于全球制药、生物科技、保健服务、医疗技术及生命科学之企业(「医疗保健企业」),以期达到基金之回报目标。子基金之资产(不包括现金及与现金相当之财产)至少67%将投资于医疗保健企业之权益证券。此等证券之发行人可位于任何国家,包括新兴市场。可辅助持有债权证券、现金及约当现金。子基金可投资于可转让证券集体投资计画及其他集体投资计画。子基金可投资于任何货币之资产,且子基金之货币曝险可进行避险或参考基金指标进行管理。子基金可为避险目的及有效管理投资组合而投资于衍生性金融工具。
名称 | 标题 | 任期 | 至 |
---|---|---|---|
Bartjan van Hulten | Portfolio Manager | 2024 | now |
背景介紹 | Mr. van Hulten, Executive Director, is an analyst in the U.S. Equity Research Group based in London, specializing in healthcare. Additionally, Mr. van Hulten was named a co-portfolio manager on the JPMorgan Global Healthcare strategy as of March 1, 2024. | ||
Dominic Valder | - | 2022 | now |
Holly Morris | - | 2022 | 2024 |
背景介紹 | Ms. Fleiss is a Managing Director at JPMIM and a co-portfolio manager in the JPMorgan U.S. Equity Group. She has been with the firm since 2012. | ||
Matthew G. Cohen | Managing Director | 2015 | 2024 |
背景介紹 | Matthew G. Cohen, M.D., managing director, is a research analyst in the U.S. Equity Group. An employee since 2005, Dr. Cohen has been portfolio manager since 2015 and a research analyst in the firm’s U.S. Equity Group since 2005. Before joining the firm, Matthew was a senior healthcare analyst at Medici Healthcare and a senior analyst covering medical products at Narragansett Asset Management, a New York-based healthcare hedge fund. Prior to that, Dr. Cohen was a resident surgeon in the Department of General Surgery at the North Shore University Hospital NYU School of Medicine. Matthew holds an M.B.A. from New York University Stern School of Business and an M.D. from McGill University in Montreal. | ||
Anne Marden | - | 2009 | 2023 |
背景介紹 | Anne Marden, managing director, is a research analyst with the European Equity Research Team with responsibility for the pharmaceutical and healthcare sectors, and is co-portfolio manager of the Global Healthcare Fund. An employee since 1986, she obtained a B.A. in economics from Princeton and earned an M.B.A. from INSEAD. She is a holder of the CFA designation. | ||
Laurence McGrath | Executive Director | 2019 | 2022 |
背景介紹 | Laurence McGrath, executive director, is an analyst in Equity Research with over 20 years of industry experience. An employee since 2010, Laurence is responsible for analysing and investing in the U.S. Large Cap healthcare equipment and services sector. Before joining JPMorgan, he was a healthcare equipment and services analyst with Pioneer Investments. He holds a Bachelor of Commerce in banking and finance from the University College Dublin and a M.Sc. in investment and treasury management from Dublin City University. | ||
Premal Pajwani | - | 2014 | 2017 |
Scott Braunstein | Portfolio Manager, Research Analyst | 2009 | 2014 |
背景介紹 | Scott Braunstein is a portfolio manager and research analyst of pharmaceuticals and medical technology stocks and is a co-analyst of the Analyst Portfolio Strategy of JPMIM since July, 2004. Prior to joining JPMIM, he worked from 2000 to 2002 at Deutsche Bank Alex Brown and from 1999 to 2000 as Director of Operations for Defined Health. |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核